Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31289594 | 1.00 | SMN1; SMN2 (0.39) | SMN1; SMN2KDM4EGABRA5LMNAATM | |
| SCHEMBL29358985 | 1.00 | SMN1; SMN2 (0.39) | SMN1; SMN2KDM4EGABRA5LMNAATM | |
| SCHEMBL8338895 | 0.90 | GABRA5 (0.42) | SMN1; SMN2KDM4EGABRA5LMNANPC1 | |
| SCHEMBL2851872 | 0.90 | GABRA5 (0.42) | SMN1; SMN2KDM4EGABRA5LMNANPC1 | |
| SCHEMBL2851880 | 0.90 | GABRA5 (0.42) | SMN1; SMN2KDM4EGABRA5LMNANPC1 | |
| SCHEMBL26935195 | 0.85 | PKM (0.37) | GABRA5HIF1ACD274PKM | |
| SCHEMBL7171950 | 0.84 | MAPK1 (0.41) | KDM4EMAPK1HIF1A | |
| SCHEMBL7171946 | 0.84 | MAPK1 (0.41) | KDM4EMAPK1HIF1A | |
| SCHEMBL9004438 | 0.83 | ATM (0.34) | SMN1; SMN2KDM4ELMNAATMNPC1 | |
| SCHEMBL11937285 | 0.83 | CD274 (0.38) | GABRA5HIF1ACD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12464971-B2 | Sowing device and method for treating seeds during planting | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-07-31 | — | — | US | disclosed |
| CN-113873886-A | Overcoat compositions | 特洛伊公司 | 2021-12-31 | — | — | CN | disclosed |
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-11-30 | — | — | US | disclosed |
| EP-2670239-B1 | FORMULATION FOR THE ANTIMICROBIAL AND FUNGICIDAL TREATMENT OF POLYMERIC MATERIALS, IN PARTICULAR OF PAINTS AND COATINGS | SANITIZED AG (CH) | 2015-08-12 | — | — | EP | disclosed |
| WO-2014102228-A1 | FORMULATION FOR THE ANTIMICROBIAL TREATMENT OF POLYMER COMPOSITIONS | SANITIZED AG (CH) | 2014-07-03 | — | — | WO | disclosed |
| EP-2749167-A1 | Formulation for the antimicrobial treatment of polyvinyl chloride compositions | Sanitized AG (CH) | 2014-07-02 | — | — | EP | disclosed |
| EP-2670239-A1 | FORMULATION FOR THE ANTIMICROBIAL AND FUNGICIDAL TREATMENT OF POLYMERIC MATERIALS, IN PARTICULAR OF PAINTS AND COATINGS | Sanitized AG (CH) | 2013-12-11 | — | — | EP | disclosed |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | AVENTIS AGRICULTURE (FR) | 2013-12-05 | — | — | US | disclosed |
| US-8445519-B2 | 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof | AVENTIS AGRICULTURE (FR) | 2013-05-21 | — | — | US | disclosed |
| EP-0714420-A1 | MOULD-RESISTANT EMULSION PAINTS | BAYER AG (DE) | 1996-06-05 | — | — | EP | disclosed |
| EP-0713485-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AG (DE) | 1996-05-29 | — | — | EP | disclosed |
| WO-1996010915-A1 | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-04-18 | — | — | WO | disclosed |
| EP-0690894-A1 | PAINTS CONTAINING n-ALKYL-N-AZOLS AS PRESERVATIVES | BAYER AG (DE) | 1996-01-10 | — | — | EP | disclosed |
| WO-1995034204-A1 | BACTERICIDE THIADIAZOLIDINONES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-12-21 | — | — | WO | disclosed |
| WO-1995024997-A1 | COMBINATIONS OF ACTIVE INSECTICIDE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-09-21 | — | — | WO | disclosed |
| WO-1995012315-A1 | STABILISATION OF IODINE COMPOUNDS USING INORGANIC SUPPORTING MATERIALS FOR USE IN MATERIAL PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1995-05-11 | — | — | WO | disclosed |
| WO-1995006091-A1 | MOULD-RESISTANT EMULSION PAINTS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-03-02 | — | — | WO | disclosed |
| WO-1995004722-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-16 | — | — | WO | disclosed |
| WO-1994021734-A1 | PAINTS CONTAINING n-ALKYL-N-AZOLS AS PRESERVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | IFNG, TLR1, IDO1 | SMN1; SMN2 4749/4885KDM4E 1828/4885GABRA5 2965/4885 |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | CYP1B1, CYP51A1, CYP1A1 | SMN1; SMN2 1500/4885KDM4E 852/4885GABRA5 767/4885 |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | CBR3, CBR1, NR5A2 | SMN1; SMN2 3774/4885KDM4E 3120/4885GABRA5 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.